Add BrightSurf on Google Email

The Malawi government's program to cut childhood pneumonia deaths

The Malawi government has introduced a national program to deliver effective pneumonia treatment, known as standard case management, to children. This initiative aims to reduce the high mortality rate of childhood pneumonia in low-income countries by providing timely and appropriate antibiotic therapy and oxygen support.

SourcePLOS·JournalPLOS Medicine·DateNov 9, 2009

Clots traveling from lower veins may not be the cause of pulmonary embolism in trauma patients

A Massachusetts General Hospital study found no evidence of deep venous thrombosis in most trauma patients with pulmonary embolism, questioning the current understanding of the condition's origin. The researchers suggest that clots may form independently in the lungs, potentially revolutionizing the way PE is prevented and treated.

SourceMassachusetts General Hospital·JournalArchives of Surgery·DateOct 19, 2009

Healing badly damaged lungs: Distinct set of white blood cells found to set the pace of wound repair

Researchers at Johns Hopkins Medicine have identified a distinct set of white blood cells called regulatory T cells that play a crucial role in wound repair after serious lung injury. The study found that these cells can be sped up or slowed down, either aiding or hindering healing in severely damaged lung tissue.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateSep 21, 2009

Scientists identify gene for short-circuiting excess mucus in lung disease, common colds

Researchers have identified a genetic switch that causes excessive mucus in the lungs, shedding light on a medical mystery. The study found that a transcription factor called SPDEF regulates a chain of genes involved in mucus production, and blocking its influence may be a potential pathway for new treatments.

SourceCincinnati Children's Hospital Medical Center·JournalJournal of Clinical Investigation·DateSep 14, 2009

Still holding their breath: Mortality on lung transplant wait list remains high for some

New research finds that mortality among patients with idiopathic pulmonary arterial hypertension (IPAH) awaiting lung transplant has not decreased, despite implementation of a new allocation system. The study suggests that key prognostic indicators in IPAH are not adequately captured by the current LAS algorithm.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 24, 2009

U-M researchers discover therapeutic target that could help patients with pulmonary fibrosis

Researchers at the University of Michigan have identified a novel gene and enzyme that may hold the key to treating idiopathic pulmonary fibrosis, a life-threatening lung disease. The discovery could lead to new treatments for not only pulmonary fibrosis but also other organ-based diseases such as cardiac and kidney fibrosis.

SourceMichigan Medicine - University of Michigan·JournalNature Medicine·DateAug 23, 2009

Cellular crosstalk linked to lung disease

Researchers identified a critical crosstalk pathway between lung epithelial cells and airway smooth muscle cells, contributing to lung diseases like asthma and pulmonary hypertension. The study provides potential new therapeutic targets for treating these conditions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 17, 2009

How to make a lung

Researchers found that Wnt2 and Wnt2b molecules are crucial for specifying lung progenitor cells in the foregut region. Without these molecules, animals fail to develop lungs, highlighting their importance in treating respiratory diseases. The study's findings also suggest a connection between pulmonary and cardiac development.

SourceUniversity of Pennsylvania School of Medicine·JournalDevelopmental Cell·DateAug 17, 2009

Lung volume reduction surgery shown to prolong and improve life for some emphysema patients

Patients who underwent lung reduction surgery showed a significant survival benefit compared to medical treatment, with an average time until a 'composite event' of two years. The procedure also improved quality of life for at least five years post-operative period, especially in patients with upper-lobe-predominant emphysema.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJul 23, 2009

Even healthy lungs labor at acceptable ozone levels

Researchers found that even at low ozone concentrations, healthy individuals can experience significant decreases in lung function after moderate exercise. The study suggests that healthier individuals may exhibit individual variability in their responses to ozone, with some showing strong sensitivity while others are less affected.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJul 23, 2009

LSUHSC shows for first time infant inhalation of ultrafine air pollution linked to adult lung disease

Early exposure to airborne ultrafine particulate matter in infancy has been linked to chronic obstructive pulmonary disease (COPD) and asthma later in life. This study found that infant inhalation of ultrafine air pollution caused genetic defects leading to dysfunctional proteins and permanent changes in immune responses.

Could science use the common cold to cure cystic fibrosis?

Researchers at University of North Carolina have discovered a new approach to delivering a corrected CF gene to lung cells using parainfluenza virus, which could potentially cure cystic fibrosis lung disease. The method has shown promise in laboratory models and may pave the way for future clinical trials.

SourcePLOS·JournalPLOS Biology·DateJul 20, 2009

Scientists advance safety of nanotechnology

Researchers have discovered a mechanism by which nanoparticles cause lung damage, triggering programmed cell death through autophagy. They also found that blocking this process with an autophagy inhibitor can counteract the damage, providing a promising lead for developing safety strategies for nanotechnology.

SourceOxford University Press UK·JournalJournal of Molecular Cell Biology·DateJun 10, 2009